These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13741405)

  • 21. Differentiation of polycythemia vera and secondary polycythemia by arterial oxygen saturation and pulmonary function tests.
    FISHER JM; BEDELL GN; SEEBOHM PM
    J Lab Clin Med; 1957 Sep; 50(3):455-63. PubMed ID: 13463462
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic approaches to polycythemia vera in 2004.
    Pahl HL
    Expert Rev Mol Diagn; 2004 Jul; 4(4):495-502. PubMed ID: 15225097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polycythemia vera and 2,3-diphosphoglycerate deficiency. Apropos of 2 cases].
    Aubert I; Aubert L; Quilichini R; Vanuxem D; Carcassonne Y
    Sem Hop; 1983 Oct; 59(39):2709-11. PubMed ID: 6316526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated cerebellar infarction as a presenting symptom of polycythemia vera.
    Hilzenrat N; Zilberman D; Sikuler E
    Acta Haematol; 1992; 88(4):204-6. PubMed ID: 1292311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycythemia vera masked due to severe iron deficiency anemia.
    Kambali S; Taj A
    Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):38-40. PubMed ID: 27614230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolic complications of polycythemia: polycythemia vera versus smokers' polycythemia.
    Schwarcz TH; Hogan LA; Endean ED; Roitman IT; Kazmers A; Hyde GL
    J Vasc Surg; 1993 Mar; 17(3):518-22; discussion 522-3. PubMed ID: 8445747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Laboratory findings in polycythemia vera and polycythemia secundaria].
    Frick PG
    Dtsch Med Wochenschr; 1967 Apr; 92(14):669-70. PubMed ID: 6024541
    [No Abstract]   [Full Text] [Related]  

  • 28. Polycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parameters.
    Usman M; Bilwani F; Kakepoto GN; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2004 May; 54(5):249-51. PubMed ID: 15270182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern Pennsylvania.
    Seaman V; Jumaan A; Yanni E; Lewis B; Neyer J; Roda P; Xu M; Hoffman R
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):534-40. PubMed ID: 19190168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary approach to essential thrombocythemia and polycythemia vera.
    Aruch D; Mascarenhas J
    Curr Opin Hematol; 2016 Mar; 23(2):150-60. PubMed ID: 26717193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
    Moliterno AR; Hankins WD; Spivak JL
    N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
    Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
    N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extramyocardial factors in the electrocardiogram of high altitude residents].
    Gamboa R
    Arch Inst Biol Andina; 1970 Dec; 3(56):234-51. PubMed ID: 5526857
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myleran therapy of erythrocythemia vera].
    KIRCHMAYER S; SZARBINSKI T
    Pol Tyg Lek; 1961 Jan; 16():173-6. PubMed ID: 13756210
    [No Abstract]   [Full Text] [Related]  

  • 38. Aquagenic Pruritus in Polycythemia Vera: Clinical Characteristics.
    Lelonek E; Matusiak Ł; Wróbel T; Szepietowski JC
    Acta Derm Venereol; 2018 Apr; 98(5):496-500. PubMed ID: 29437189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipemia and myocardial infarction in polycythemia vera.
    Benjamin D; Yeshurun D; Charnilas J; Pinkhas J
    Isr J Med Sci; 1978 Nov; 14(11):1162-4. PubMed ID: 750543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prologue: polycythemia vera. The closing of the Wasserman-Polycythemia Vera Study Group era.
    Berlin NI
    Semin Hematol; 1997 Jan; 34(1):1-5. PubMed ID: 9025156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.